Fundsmith Emerging Equities Trust PLC (LON:FEET)’s stock price fell 1.7% during mid-day trading on Monday . The stock traded as low as GBX 1,150 ($15.03) and last traded at GBX 1,150.05 ($15.03), 71,307 shares were traded during mid-day trading. An increase of 124% from the average session volume of 31,834 shares. The stock had previously closed at GBX 1,170 ($15.29).

JPEL Private Equity Ltd (LON:JPEL)’s share price traded down 17.4% on Monday . The stock traded as low as GBX 1.42 ($0.02) and last traded at GBX 1.42 ($0.02), 10,716 shares changed hands during mid-day trading. A decline of 32% from the average session volume of 15,701 shares. The stock had previously closed at GBX 1.72 ($0.02).

CRH Medical Corp (TSE:CRH) shares shot up 0.8% during trading on Monday . The stock traded as high as C$3.85 and last traded at C$3.83, 23,426 shares changed hands during mid-day trading. A decline of 78% from the average session volume of 108,244 shares. The stock had previously closed at C$3.80.

Invesco Defensive Equity ETF (NYSEARCA:DEF)’s share price dropped 0.5% during trading on Monday . The company traded as low as $53.54 and last traded at $53.55, approximately 7,860 shares traded hands during mid-day trading. A decline of 56% from the average daily volume of 18,021 shares. The stock had previously closed at $53.83.

Casey’s General Stores Inc (NASDAQ:CASY) – Equities research analysts at Jefferies Financial Group issued their Q1 2021 earnings per share estimates for Casey’s General Stores in a report issued on Tuesday, June 11th, Zacks Investment Research reports. Jefferies Financial Group analyst C. Mandeville expects that the company will post earnings per share of $2.04 for the quarter. Jefferies Financial Group currently has a “Buy” rating and a $167.00 target price on the stock. Jefferies Financial Group also issued estimates for Casey’s General Stores’ Q2 2021 earnings at $2.41 EPS.

Concrete Pumping Holdings Inc (NASDAQ:BBCP) – Equities research analysts at William Blair lowered their FY2020 earnings estimates for shares of Concrete Pumping in a report released on Monday, June 10th, according to Zacks Investment Research. William Blair analyst T. Mulrooney now anticipates that the company will post earnings per share of $0.15 for the year, down from their prior estimate of $0.26. William Blair currently has a “Outperform” rating and a $5.31 target price on the stock.

ArcBest Corp (NASDAQ:ARCB) – Investment analysts at SunTrust Banks reduced their Q3 2019 EPS estimates for shares of ArcBest in a note issued to investors on Wednesday, June 12th, according to Zacks Investment Research. SunTrust Banks analyst S. Benjamin now expects that the transportation company will post earnings of $1.43 per share for the quarter, down from their previous estimate of $1.49. SunTrust Banks also issued estimates for ArcBest’s Q4 2019 earnings at $0.95 EPS and Q4 2020 earnings at $1.08 EPS.

Axcelis Technologies Inc (NASDAQ:ACLS) – Stock analysts at B. Riley decreased their Q3 2019 earnings estimates for Axcelis Technologies in a research report issued to clients and investors on Wednesday, June 12th, according to Zacks Investment Research. B. Riley analyst C. Ellis now anticipates that the semiconductor company will post earnings per share of $0.06 for the quarter, down from their previous estimate of $0.08. B. Riley also issued estimates for Axcelis Technologies’ FY2019 earnings at $0.52 EPS, Q2 2020 earnings at $0.29 EPS, Q3 2020 earnings at $0.33 EPS, Q4 2020 earnings at $0.38 EPS and FY2020 earnings at $1.28 EPS.

First Merchants Co. (NASDAQ:FRME) – Research analysts at DA Davidson dropped their FY2020 EPS estimates for First Merchants in a research note issued to investors on Tuesday, June 18th, according to Zacks Investment Research. DA Davidson analyst K. Reevey now anticipates that the bank will post earnings of $3.68 per share for the year, down from their prior forecast of $3.72.

InVitae Corp (NYSE:NVTA) – Equities researchers at Oppenheimer decreased their Q3 2019 earnings per share (EPS) estimates for shares of InVitae in a report released on Monday, June 17th, according to Zacks Investment Research. Oppenheimer analyst K. Degeeter now expects that the medical research company will earn ($0.59) per share for the quarter, down from their prior estimate of ($0.54). Oppenheimer has a “Outperform” rating and a $30.00 price target on the stock. Oppenheimer also issued estimates for InVitae’s Q4 2019 earnings at ($0.49) EPS, FY2019 earnings at ($2.08) EPS, FY2020 earnings at ($1.66) EPS and FY2021 earnings at ($1.05) EPS.